In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
In this video, Sarah Wise, MD, discusses updates to the International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis 2023, including how the updates should be used to improve clinical...
In this video, Jonathan A. Bernstein, MD, explains the results of a study that focused on efficacy of biologics in patients with severe allergic asthma, including omalizumab, belimumab, mepolizumab,...
In this video, dermatologist Steven Feldman, MD, PhD, speaks with allergist and immunologist Jason Caldwell, DO, and pediatric dermatologist Robert Sidbury, MD, MPH, about atopic dermatitis (AD), including...
In this video, Amy S. Paller, MD, discusses the efficacy and safety of dupilumab for patients with erythrodermic atopic dermatitis (AD), what these results mean for patients with severe AD, and how her...
Douglas Leventhal, MD, who is an ear, nose, and throat specialist at ENT and Allergy Associates in Oradell, New Jersey, walks through the steps of a septoplasty.
Rachael Buck, PhD, discusses the potential of a new infant formula she and her research team developed, which harnesses the unique qualities and benefits of human milk oligosaccharides (an alternative to...
Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
Michael Banks, MD, discusses the new genomic test created to determine a patient's tumor mutation burden, which could help identify patients that would benefit from immunotherapy.
Larry Smarr, Founding Director, CALIT2, details the growing epidemic of children, especially those with gastrointestinal disorders, who were not exposed to the necessary microbiomes during the formative...
